Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-6-27
pubmed:abstractText
Quantitative real-time PCR was performed for C13orf19, a gene located on chromosome 13q and previously described to be down-regulated in prostate carcinoma, on different cancer cell lines, on matched prostate tissues from 61 patients with prostate carcinoma and on matched kidney tissues from 23 patients with renal clear cell carcinoma. All data were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), porphobilinogen deaminase (PBGD) and hypoxanthine guanine phosphoribosyl transferase (HPRT) mRNA expression. A C13orf19 quantitative PCR (QPCR) showed the mRNA to be down-regulated in matched prostate tissues (P=0.007 and lower, paired Student's t-test). However, an at least 1.5-fold C13orf19 mRNA downregulation was observed in samples from 28 patients (46%) and an at least 1.5-fold upregulation was observed in samples from 17 patients (28%). In contrast, C13orf19 mRNA alterations in expression seemed to be random events in kidney cancers.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0304-3835
pubmed:author
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
225
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
253-60
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Quantification of C13orf19/P38IP mRNA expression by quantitative real-time PCR in patients with urological malignancies.
pubmed:affiliation
Department of Urology, Technical University of Dresden, Fetscherstr. 74, D-01307 Dresden, Germany. uta.schmidt2@mailbox.tu-dresden.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't